A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer
Abstract Background Despite evidence indicating the dominance of cell-of-origin signatures in molecular tumor patterns, translating these genome-wide patterns into actionable insights has been challenging. This study introduces breast cancer cell-of-origin signatures that offer significant prognosti...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2024-09-01
|
| Sarja: | Breast Cancer Research |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s13058-024-01876-9 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
